feed,title,long_url,short_url
Benzinga,Open Questions On Safety Lingers After Eisai-Biogen's Detailed Lecanemab Data For Alzheimer's,https://benzinga.com/general/biotech/22/11/29901945/open-questions-on-safety-lingers-after-eisai-biogens-detailed-lecanemab-data-for-alzheimers,https://bit.ly/3UjpGH4
Benzinga,Workday Stock Is Ripping Higher Wednesday: Here's Why,https://benzinga.com/news/earnings/22/11/29906476/workday-stock-is-ripping-higher-wednesday-heres-why,https://bit.ly/3VpCLQr
Benzinga,"Bluebird Bio Sells Priority Review Voucher For $102M, Strengthening Its Financial Position",https://benzinga.com/general/biotech/22/11/29905533/bluebird-bio-sells-priority-review-voucher-for-102m-strengthening-its-financial-position,https://bit.ly/3UiYUyz
Benzinga,Ominous Death Cross Forms On M&T Bank's Chart,https://benzinga.com/markets/22/11/29906659/ominous-death-cross-forms-on-m-t-banks-chart,https://bit.ly/3VivxxN
Benzinga,Will Investors Notice Exciting Sign On IBM's Chart?,https://benzinga.com/markets/22/11/29906653/will-investors-notice-exciting-sign-on-ibms-chart,https://bit.ly/3FbFdEz
Benzinga,Will Investors Notice Exciting Sign On Caterpillar's Chart?,https://benzinga.com/markets/22/11/29906636/will-investors-notice-exciting-sign-on-caterpillars-chart,https://bit.ly/3FfhZ0o
Benzinga,Hopeful Golden Cross Forms On BBVA's Chart,https://benzinga.com/markets/22/11/29906625/hopeful-golden-cross-forms-on-bbvas-chart,https://bit.ly/3VITaPT
